These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29665444)

  • 1. NDM-1- and OXA-23-producing Acinetobacter baumannii isolated from intensive care unit patients in Tunisia.
    Maamar E; Alonso CA; Ferjani S; Jendoubi A; Hamzaoui Z; Jebri A; Saidani M; Ghedira S; Torres C; Boubaker IB
    Int J Antimicrob Agents; 2018 Dec; 52(6):910-915. PubMed ID: 29665444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical epidemiology and resistance mechanisms of carbapenem-resistant Acinetobacter baumannii, French Guiana, 2008-2014.
    Mahamat A; Bertrand X; Moreau B; Hommel D; Couppie P; Simonnet C; Kallel H; Demar M; Djossou F; Nacher M
    Int J Antimicrob Agents; 2016 Jul; 48(1):51-55. PubMed ID: 27236843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The first nationwide multicenter study of Acinetobacter baumannii recovered in Serbia: emergence of OXA-72, OXA-23 and NDM-1-producing isolates.
    Lukovic B; Gajic I; Dimkic I; Kekic D; Zornic S; Pozder T; Radisavljevic S; Opavski N; Kojic M; Ranin L
    Antimicrob Resist Infect Control; 2020 Jul; 9(1):101. PubMed ID: 32631451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-genome sequencing of NDM-1-producing ST85 Acinetobacter baumannii isolates from Tunisia.
    Jaidane N; Naas T; Oueslati S; Bernabeu S; Boujaafar N; Bouallegue O; Bonnin RA
    Int J Antimicrob Agents; 2018 Dec; 52(6):916-921. PubMed ID: 29857033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in ICU of the eastern Heilongjiang Province, China.
    Zhao Y; Hu K; Zhang J; Guo Y; Fan X; Wang Y; Mensah SD; Zhang X
    BMC Infect Dis; 2019 May; 19(1):452. PubMed ID: 31113374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predominance of international clone 2 OXA-23-producing-Acinetobacter baumannii clinical isolates in Greece, 2015: results of a nationwide study.
    Pournaras S; Dafopoulou K; Del Franco M; Zarkotou O; Dimitroulia E; Protonotariou E; Poulou A; Zarrilli R; Tsakris A;
    Int J Antimicrob Agents; 2017 Jun; 49(6):749-753. PubMed ID: 28427842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence and spread of a multidrug-resistant Acinetobacter baumannii clone producing both the carbapenemase OXA-23 and the 16S rRNA methylase ArmA.
    Brigante G; Migliavacca R; Bramati S; Motta E; Nucleo E; Manenti M; Migliorino G; Pagani L; Luzzaro F; Viganò FE
    J Med Microbiol; 2012 May; 61(Pt 5):653-661. PubMed ID: 22282459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
    Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W
    Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal relatedness and biofilm formation of OXA-23-producing carbapenem resistant Acinetobacter baumannii isolates from hospital environment.
    Aliramezani A; Douraghi M; Hajihasani A; Mohammadzadeh M; Rahbar M
    Microb Pathog; 2016 Oct; 99():204-208. PubMed ID: 27569533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emergence of a novel sequence type of MDR Acinetobacter baumannii from the intensive care unit of an Egyptian tertiary care hospital.
    Ghaith DM; Zafer MM; Al-Agamy MH; Alyamani EJ; Booq RY; Almoazzamy O
    Ann Clin Microbiol Antimicrob; 2017 May; 16(1):34. PubMed ID: 28486994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy.
    Mezzatesta ML; D'Andrea MM; Migliavacca R; Giani T; Gona F; Nucleo E; Fugazza G; Pagani L; Rossolini GM; Stefani S
    Clin Microbiol Infect; 2012 Feb; 18(2):160-6. PubMed ID: 21722261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OXA-23 and ISAba1-OXA-66 class D β-lactamases in Acinetobacter baumannii isolates from companion animals.
    Ewers C; Klotz P; Leidner U; Stamm I; Prenger-Berninghoff E; Göttig S; Semmler T; Scheufen S
    Int J Antimicrob Agents; 2017 Jan; 49(1):37-44. PubMed ID: 27890443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa - an update.
    Lowings M; Ehlers MM; Dreyer AW; Kock MM
    BMC Infect Dis; 2015 Nov; 15():521. PubMed ID: 26573617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endemic carbapenem-nonsusceptible
    Saharman YR; Karuniawati A; Sedono R; Aditianingsih D; Sudarmono P; Goessens WHF; Klaassen CHW; Verbrugh HA; Severin JA
    Antimicrob Resist Infect Control; 2018; 7():5. PubMed ID: 29344351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.
    Lee YT; Fung CP; Wang FD; Chen CP; Chen TL; Cho WL
    J Microbiol Immunol Infect; 2012 Feb; 45(1):43-51. PubMed ID: 22169123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection of metallo-β-lactamase NDM-1- and OXA-23 carbapenemase-producing Acinetobacter baumannii in Libyan hospitals.
    Mathlouthi N; El Salabi AA; Ben Jomàa-Jemili M; Bakour S; Al-Bayssari C; Zorgani AA; Kraiema A; Elahmer O; Okdah L; Rolain JM; Chouchani C
    Int J Antimicrob Agents; 2016 Jul; 48(1):46-50. PubMed ID: 27216382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imported and intensive care unit-born Acinetobacter baumannii clonal complexes: one-year prospective cohort study in intensive care patients.
    Martins N; Martins IS; de Freitas WV; de Matos JA; Girão VB; Coelho-Souza T; Maralhães AC; Cacci LC; de Figueiredo MP; Dias RC; Costa-Lourenço AP; Ferreira AL; Dalla-Costa L; Nouér SA; Santoro-Lopes G; Riley LW; Moreira BM
    Microb Drug Resist; 2013 Jun; 19(3):216-23. PubMed ID: 23336529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal dissemination of extensively drug-resistant Acinetobacter baumannii producing an OXA-23 β-lactamase at a teaching hospital in Shanghai, China.
    Li Y; Guo Q; Wang P; Zhu D; Ye X; Wu S; Wang M
    J Microbiol Immunol Infect; 2015 Feb; 48(1):101-8. PubMed ID: 24863499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of OXA-23 and OXA-58 Carbapenemases Coexpressed in Clinical Isolates of Acinetobacter baumannii in Tunisia.
    Mathlouthi N; Ben Lamine Y; Somai R; Bouhalila-Besbes S; Bakour S; Rolain JM; Chouchani C
    Microb Drug Resist; 2018 Mar; 24(2):136-141. PubMed ID: 28691891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.